BYAH
Park Ha Biological Technology Co., Ltd. Ordinary Shares
There isn't enough reported data to score BYAH yet.
NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
BYAH Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Strong |
BYAH's revenue and balance sheet are currently strong, but its profitability and cash flow are weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
BYAH PE Valuation
BYAH has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
BYAH Forward outlook
There aren't enough analyst estimates for BYAH to show an outlook.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
BYAH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$506.83 | -5133% |
| Q3 2025 | -$440.10 | -4979% |
| Q2 2025 | -$408.34 | -4961% |
| Q1 2025 | -$137.87 | -1248% |
| Q4 2024 | $10.07 | -36% |
NKE has the stronger earnings trend. Trailing diluted EPS is down 5,133% for BYAH versus NKE up 7.2%.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
BYAH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3M | +1.5% |
| Q4 2025 | $1.3M | -16% |
| Q3 2025 | $642.8K | -16% |
| Q2 2025 | $1.2M | +45% |
| Q4 2024 | $1.5M | +41% |
| Q3 2024 | $764.5K | +41% |
| Q2 2024 | $852.9K | -38% |
| Q1 2024 | $426.5K | -38% |
BYAH has the stronger quarterly revenue trend. Revenue is up 1.5% for BYAH versus down 4.3% for NKE.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -77% | +1515 points |
| Q1 2026 | -77% | N/A |
| Q4 2025 | -345% | -391 points |
| Q3 2025 | -345% | -391 points |
| Q2 2025 | -1591% | -1602 points |
| Q4 2024 | 46% | -0.6 points |
| Q3 2024 | 46% | -0.6 points |
| Q2 2024 | 11% | -38 points |
BYAH's operating margin was −77% last quarter, up 1514 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
BYAH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$338.8K | -239% |
| Q1 2026 | -$169.4K | -239% |
| Q4 2025 | -$246.2K | -129% |
| Q3 2025 | -$123.1K | -129% |
NKE has the stronger cash trend. Its trailing FCF is down 52% versus its history, compared with BYAH at down 245%.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
BYAH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.4x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
BYAH has more cash than debt.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
BYAH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 13.0 | Oversold |
| Stochastic | 4.7 | Oversold |
BYAH's weekly RSI is 13 (oversold) and its Stochastic is 5 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
BYAH PE vs Consumer Cyclical Sector
BYAH has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
BYAH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.25 | 35% below |
| 20 week MA | $2.93 | 50% below |
| 50 week MA | $18.5 | 92% below |
NKE has stronger trend alignment. BYAH is above 0 of 3 weekly averages versus NKE above 1 of 5.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
BYAH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $193.2 | $73.2 | -62% |
| 2026 YTD | $73.2 | $1.47 | -98% |
BYAH has finished every year since 2025 lower, and it's down 98% so far in 2026.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over BYAH on returns for 2026, with the stronger performance.